{"nct_id":"NCT02720068","title":"Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001)","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2016-05-02","start_date_type":"ACTUAL","primary_completion_date":"2024-03-15","primary_completion_date_type":"ACTUAL","completion_date":"2024-03-15","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}